A medical communications agency, by the numbers
We have some of the brightest minds in oncology and hematology medical communications. Our global resources, strategic programs, and longstanding relationships with key scientific leaders provide our life science partners with future-focused, evidence-based solutions – all designed to improve clinical decision making and enhance patient outcomes. View our Facts & Figures Infographic.
The power of evidence-based, omnichannel innovation
Helping our partners successfully navigate the complex oncology and hematology marketplace is a critical part of what we do best. That’s why we created D3 – our unique, 3-phase approach provides competitive solutions to your most difficult challenges, every time.
Better decisions start with strategic expertise
We partner with the world’s best
Up-to-date stories, articles, and insights from the TRM Oncology team
Across the globe, both patients and healthcare providers (HCPs) are embracing a digital-first attitude towards health-related resources. Studies show the demonstration of online users looking for healthcare content is significant.
Many companies are riding the wave of predictive targeting, an approach to marketing that analyzes user data to predict their behavior, and pharmaceutical companies should take note of opportunities to adopt the trend.
With the shifting digital landscape, pharma companies are now using strategies to engage key opinion leaders (KOLs) using online techniques. So why don’t we recruit KOLs through online channels as well? This post will discuss the struggles of approaching emerging KOLs and ways to identify and engage KOLs online. One of the best practices is […]
Get the latest insights on medical communications and the pharma industry.